$1.37 Billion is the total value of Bronte Capital Management Pty Ltd.'s 27 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 28.6% . Bronte Capital Management Pty Ltd. is a registered-investment adviser.
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| IWM | Buy | ISHARES TRcall | $344,102,000 | +3.1% | 156,100 | +8.1% | 25.18% | +5.8% |
| SPY | Sell | SPDR S&P 500 ETF TRcall | $182,640,000 | -18.7% | 42,400 | -18.9% | 13.36% | -16.6% |
| IWO | Sell | ISHARES TRcall | $135,844,000 | -16.1% | 462,700 | -10.9% | 9.94% | -13.9% |
| GOOGL | ALPHABET INCcap stk cl a | $131,473,000 | +9.5% | 49,176 | 0.0% | 9.62% | +12.3% | |
| BRKB | Sell | BERKSHIRE HATHAWAY INC DELcl b new | $113,695,000 | -3.5% | 416,558 | -1.8% | 8.32% | -1.0% |
| HLF | Buy | HERBALIFE NUTRITION LTD | $99,402,000 | -16.4% | 2,345,486 | +4.1% | 7.27% | -14.2% |
| REGN | Buy | REGENERON PHARMACEUTICALS | $75,178,000 | +14.6% | 124,224 | +5.8% | 5.50% | +17.6% |
| IBKR | Buy | INTERACTIVE BROKERS GROUP | $54,156,000 | -3.3% | 868,725 | +1.9% | 3.96% | -0.8% |
| V | VISA INC | $39,525,000 | -4.7% | 177,440 | 0.0% | 2.89% | -2.2% | |
| CTVA | Buy | CORTEVA NC | $36,189,000 | -0.9% | 859,996 | +4.5% | 2.65% | +1.7% |
| BK | BANK NEW YORK MELLON CORP | $25,811,000 | +1.2% | 497,891 | 0.0% | 1.89% | +3.8% | |
| STT | STATE STR CORP | $22,754,000 | +3.0% | 268,574 | 0.0% | 1.66% | +5.6% | |
| GOOG | ALPHABET INCcap stk cl c | $18,583,000 | +6.3% | 6,972 | 0.0% | 1.36% | +9.1% | |
| GHC | Buy | GRAHAM HLDGS CO | $14,964,000 | +0.5% | 25,399 | +8.1% | 1.10% | +3.1% |
| MO | ALTRIA GROUP INC | $13,090,000 | -4.5% | 287,561 | 0.0% | 0.96% | -2.0% | |
| BYND | BEYOND MEAT INCput | $10,526,000 | -33.2% | 100,000 | 0.0% | 0.77% | -31.4% | |
| GIS | New | GENERAL MLS INC | $10,102,000 | – | 168,870 | +100.0% | 0.74% | – |
| PM | New | PHILIP MORRIS INTL INC | $10,076,000 | – | 106,293 | +100.0% | 0.74% | – |
| SHC | New | SOTERA HEALTH CO | $4,688,000 | – | 179,279 | +100.0% | 0.34% | – |
| MDLZ | Buy | MONDELEZ INTL INCcl a | $4,638,000 | +6.4% | 79,715 | +14.2% | 0.34% | +9.0% |
| NEM | Buy | NEWMONT CORP | $3,960,000 | -14.2% | 72,921 | +0.1% | 0.29% | -11.9% |
| New | BATH & BODY WORKS INC | $3,769,000 | – | 59,794 | +100.0% | 0.28% | – | |
| VIR | New | VIR BIOTECHNOLOGY INC | $3,261,000 | – | 74,920 | +100.0% | 0.24% | – |
| MACK | MERRIMACK PHARMACEUTICALS IN | $2,651,000 | -24.4% | 548,836 | 0.0% | 0.19% | -22.4% | |
| NPO | New | ENPRO INDS INC | $2,614,000 | – | 30,000 | +100.0% | 0.19% | – |
| BNTX | Sell | BIONTECH SE-ADRsponsored ads | $1,855,000 | -24.4% | 6,795 | -38.0% | 0.14% | -22.3% |
| DBTX | DECIBEL THERAPEUTICS INC | $1,229,000 | -10.4% | 159,462 | 0.0% | 0.09% | -8.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BERKSHIRE HATHAWAY INC DEL | 20 | Q3 2023 | 22.6% |
| ALPHABET INC-CL A | 20 | Q3 2023 | 14.4% |
| HERBALIFE NUTRITION LTD | 20 | Q3 2023 | 22.0% |
| INTERACTIVE BROKERS GROUP | 20 | Q3 2023 | 12.4% |
| ALPHABET INC-CL C | 20 | Q3 2023 | 5.7% |
| VISA INC-CLASS A SHARES | 19 | Q2 2023 | 16.6% |
| CORTEVA NC | 17 | Q3 2023 | 6.2% |
| GRAHAM HOLDINGS CO-CLASS B | 13 | Q3 2023 | 2.1% |
| REGENERON PHARMACEUTICALS | 12 | Q3 2023 | 13.0% |
| STATE STREET CORP | 12 | Q2 2023 | 3.0% |
View Bronte Capital Management Pty Ltd.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| SCHEDULE 13G | 2024-02-13 |
| 13F-HR | 2024-02-07 |
| 13F-HR | 2023-11-06 |
| 13F-HR | 2023-08-08 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-03 |
| 13F-HR/A | 2022-08-08 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-05-13 |
View Bronte Capital Management Pty Ltd.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.